Trend?

Bristol-Myers Squibb ousts CEO Dolan
WALLACE WITKOWSKI
Associated Press

NEW YORK - Bristol-Myers Squibb Co. on Tuesday ousted Peter R. Dolan as chief executive at the urging of a federal monitor, who found that the drug maker's patent deal with a generic competitor violated an agreement with prosecutors.